期刊文献+

肝硬化患者凝血功能监测及临床运用 被引量:6

下载PDF
导出
摘要 目的:通过观察肝硬化时凝血四项关键指标,凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)的变化,了解其临床运用意义。方法:72例肝硬化患者和60例健康对照者进行了血浆凝血四项的检测且观察凝血功能与Chi1d-Pugh肝功能分级的关系,观察40例手术患者行相同方式手术且术后使用相同监护条件时术中出血量与术后3d血浆管引流量的变化。结果:肝硬化患者凝血四项指标变化不仅与正常人差异有显著性,而且随着肝功能损害程度的加重,凝血障碍越明显。按Child-Pugh肝功能分级,肝硬化患者随着分级加重PT、APTT、TT逐渐延长,FIB逐渐降低,降低幅度依次为A级<B级<C级,三级中的PT、APTT、TT、FIB差异均有显著性,提示PT、APTT、TT时间延长和FIB结果降低与Child-Pugh肝功能分级具有一致性。肝功能分级愈差,凝血障碍愈明显。手术患者随着肝功能分级的降低,术中出血量与术后3d血浆管引流量也在增加。结论:凝血四项指标的检测能从多方面及时、准确地反映肝硬化患者肝脏的损害程度和凝血功能情况,所以需动态地观察凝血四项指标以便对肝硬化患者的病情进行更好的监测和治疗。
出处 《实用医学杂志》 CAS 北大核心 2009年第20期3425-3426,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献10

  • 1Amitrano L, Guardascione M A, Ames P R. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis [J]. Clin Lab, 2007,53 (9-12) : 583-589.
  • 2Northup P G, Sundaram V, Fallon M B, et al. Coagulation in Liver Disease Group.Hypercoagulation and thrombophilia in liver disease [ J ]. J Thromb Haemost, 2008,6 ( 1 ) : 2-9.
  • 3Aytac S, Turkay C, Bavbek N, et al. Hemostasis and global fihrinolytic capacity in chronic liver disease [J]. Blood Coagul Fihrinolysis, 2007,18 (7) : 623-626.
  • 4Rizzo F, Papasouliotis K, Crawford E, et al. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions [J]. Res Vet Sci, 2008,85( 1 ): 166-170.
  • 5Wootla B, Nicoletti A, Patey N, et al. Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients [J]. J Immunol, 2008,180(12) : 8455-8460.
  • 6Casoinic F, Sampelean D, Badau C. Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease [J]. Rom J Intern Med, 2006,44(4) :419-426.
  • 7Negrev N N, Radev R Z, Velikova M S, et al. Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (Ⅱ, Ⅶ, Ⅸ, and Ⅹ) [J]. Int J Immunopathol Pharmacol, 2008,21 ( 1 ) :221-226.
  • 8Senzolo M, Coppell J, Cholongitas E, et al. The effects of glycosaminoglycans on coagulation: a thromboelastographic study [ J ]. Blood Coagul Fibrinolysis, 2007,18 ( 3 ) : 227-236.
  • 9Northup P G, McMahon M M, Ruhl A P, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism [ J ]. Am J Gastroenterol, 2006,101 (7) : 1524-1528.
  • 10Panasiuk A, Zak J, Panasiuk B, et al. Increase in expression of monocytic tissue factor (CD142) with monocytes and blood platelet activation in liver cirrhosis [ J ]. Blood Coagul Fibrinolysis, 2007,18 (8) : 739-744.

同被引文献52

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部